Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
Conditions: Cancer; Covid-19 Interventions: Biological: IMM-101; Other: Observation Sponsors: Canadian Cancer Trials Group; Immodulon Therapeutics Ltd; BioCan Rx; Canadian Cancer Society Research Institute (CCSRI); ATGen Canada Inc; Canadian Centre for Applied Research in Cancer Control (ARCC) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials